Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
ACS Infectious Diseases · 2025
DOI: 10.1021/acsinfecdis.5c00519 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Zhenzhen Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical…. Hauptthemen laut MEDLINE: Reverse Transcriptase Inhibitors, HIV-1, Drug Design, HIV Reverse Transcriptase. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Taishan Scholar Project of Shandong Province, Shandong University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, C…
- Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, K.U. Leuven, Herestraat 49 Postbus 1043 (09.A097), B-3000 Leuven, Belgium.
- China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, 44 West Culture Road, 250012 Jinan, Shandong, P. R. China.
ORCID-Profile: Zhenzhen Zhou, Peng Zhan, Dongwei Kang, Xinyong Liu
Förderung
- National Key Research and Development Program of China
- Taishan Scholar Project of Shandong Province
- Shandong University
- National Natural Science Foundation of China
- Shandong Laboratory Program
Zitieren
APA
Zhou, Z., Guo, J., Li, X., Wu, J., Clercq, E., Pannecouque, C., Zhan, P., Kang, D., & Liu, X. (2025). Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00519
Vancouver
Zhou Z, Guo J, Li X, Wu J, Clercq E, Pannecouque C, et al. Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00519
BibTeX
@article{Zhou2025,
author = {Zhou, Zhenzhen and Guo, Jie and Li, Xin and Wu, Jinyuan and Clercq, Erik De and Pannecouque, Christophe and Zhan, Peng and Kang, Dongwei and Liu, Xinyong},
title = {Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors},
journal = {ACS Infectious Diseases},
year = {2025},
doi = {10.1021/acsinfecdis.5c00519}
}
EUVIMED